|
|
| (6 intermediate revisions by 3 users not shown) |
| Line 1: |
Line 1: |
| ==Administration==
| | #REDIRECT[[Nitroglycerin]] |
| *Type: Vasodilator
| |
| *Dosage Forms: SL, IV
| |
| *Common Trade Names: Nitrostat
| |
| | |
| ==Adult Dosing==
| |
| Angina, acute
| |
| * 0.3 - 0.6 mg SL q5min, max: 3 doses within 15 min
| |
| * IV form: 5 mcg/min IV, increase 5-20 mcg/min q3-5min.
| |
| | |
| HTN
| |
| *5-200 mcg/min IV, start 5 mcg/min IV and increase increase 5 mcg/min q3-5min
| |
| ==Pediatric Dosing==
| |
| | |
| HTN/CHF
| |
| *1-5 mcg/kg/min IV
| |
| | |
| ==Special Populations==
| |
| *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C
| |
| *[[Lactation risk categories|Lactation risk]]: safety unknown
| |
| ===Renal Dosing===
| |
| *Adult: not defined
| |
| *Pediatric: not defined
| |
| ===Hepatic Dosing===
| |
| *Adult: not defined
| |
| *Pediatric: not defined
| |
| | |
| ==Contraindications==
| |
| *Allergy to class/drug
| |
| * pericardial tamponade
| |
| * severe anemia
| |
| * SED use
| |
| | |
| ==Adverse Reactions==
| |
| ===Serious===
| |
| *hypotension
| |
| *bradycardia
| |
| *methemoglobinemia
| |
| | |
| ===Common===
| |
| *headache
| |
| *lightheadedness
| |
| *dizziness
| |
| *flushing
| |
| *reflex tachycardia
| |
| *edema
| |
| | |
| ==Pharmacology==
| |
| *Half-life: 1-3 min
| |
| *Metabolism: liver
| |
| *Excretion: urine
| |
| | |
| ==Mechanism of Action==
| |
| Stimulates cGMP production, resulting in vascular smooth muscle relaxtion
| |
| ==Comments==
| |
| | |
| ==See Also==
| |
| | |
| ==References==
| |
| <references/>
| |
| [[Category:Drugs]]
| |
